A Phase II Study of Sagopilone (ZK 219477; ZK-EPO) in Patients With Breast Cancer and Brain Metastases
Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2011.03.024
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2011
Authors
Publisher
Elsevier BV